These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 32430342
1. Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma. Filì M, Trocme E, Herrspiegel C, Seregard S, Stålhammar G. Br J Ophthalmol; 2021 Jan; 105(1):57-62. PubMed ID: 32430342 [Abstract] [Full Text] [Related]
5. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Saconn PA, Gee CJ, Greven CM, McCoy TP, Ekstrand KE, Greven KM. Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):844-8. PubMed ID: 20171804 [Abstract] [Full Text] [Related]
7. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review. Vonk DT, Kim Y, Javid C, Gordon JD, Stea B. Brachytherapy; 2015 Nov 01; 14(5):726-33. PubMed ID: 26051804 [Abstract] [Full Text] [Related]
10. Small choroidal melanoma: outcomes following apical height dose brachytherapy. Yupari RJ, Bena J, Wilkinson A, Suh J, Singh A. Br J Ophthalmol; 2021 Aug 01; 105(8):1161-1165. PubMed ID: 32878827 [Abstract] [Full Text] [Related]
11. Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas. Espensen CA, Appelt AL, Fog LS, Thariat J, Gothelf AB, Aznar MC, Kiilgaard JF. Acta Oncol; 2020 Aug 01; 59(8):918-925. PubMed ID: 32412331 [Abstract] [Full Text] [Related]
12. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. Jones R, Gore E, Mieler W, Murray K, Gillin M, Albano K, Erickson B. Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):989-95. PubMed ID: 11958893 [Abstract] [Full Text] [Related]
13. Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaque. Salkola S, Heikkonen J, Eskelin S, Kivelä T. Retina; 2014 Oct 15; 34(10):2110-20. PubMed ID: 24978431 [Abstract] [Full Text] [Related]
15. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B, Grange JD. Am J Ophthalmol; 2004 May 15; 137(5):893-900. PubMed ID: 15126155 [Abstract] [Full Text] [Related]
16. New Zealand experience of I125 brachytherapy for choroidal melanoma. Stack R, Elder M, Abdelaal A, Hidajat R, Clemett R. Clin Exp Ophthalmol; 2005 Oct 15; 33(5):490-4. PubMed ID: 16181274 [Abstract] [Full Text] [Related]
17. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review. Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL. Brachytherapy; 2018 Oct 15; 17(6):981-989. PubMed ID: 30082188 [Abstract] [Full Text] [Related]
18. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas. Damato B, Patel I, Campbell IR, Mayles HM, Errington RD. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):392-400. PubMed ID: 15990248 [Abstract] [Full Text] [Related]